Tamoxifen and risk of endometrial cancer
- 1 January 2001
- journal article
- Published by Elsevier in The Lancet
- Vol. 357 (9249) , 65-66
- https://doi.org/10.1016/s0140-6736(05)71562-2
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Risk and prognosis of endometrial cancer after tamoxifen for breast cancerThe Lancet, 2000
- BRCA1 and BRCA2 Mutation Analysis of 208 Ashkenazi Jewish Women with Ovarian CancerAmerican Journal of Human Genetics, 2000
- Tumour biological features of BRCA1-induced breast and ovarian cancerEuropean Journal Of Cancer, 1997